2927
Fiscal year ends August Quarters are offset from the calendar — Q1 is Sep–Nov

AFC-HD AMS Life Science Co., Ltd. is a Japanese conglomerate operating primarily in the healthcare and pharmaceutical sectors. The company's core business involves the contract manufacturing and OEM production of health foods, supplements, and cosmetics, supported by research and development capabilities. Its pharmaceutical segment focuses on the manufacturing and sales of medical, general, and generic drugs, including traditional Chinese medicine. The group also operates a diversified portfolio of businesses including department stores, food and beverage services, tourism, and real estate management. Key subsidiaries include Honzo Pharmaceutical for drug production, Nihon Yobou Ika Kenkyusho for health product R&D, and Saikaya for department store operations. The company serves domestic and international markets, with specific subsidiaries handling sales and raw material procurement in China. It maintains GMP-certified facilities for health food production and offers total production management from planning to final product delivery.

Summarised from the annual report, fiscal year ended Aug 2025

Industry Drug Manufacturers - General Homepage ams-life.com
Sector Healthcare IR page —
Tags
contract manufacturing, health foods, cosmetics, traditional chinese medicine, generic drugs, department stores, food and beverage, real estate management, tourism, oem production, Honzo Pharmaceutical, Nihon Yobou Ika Kenkyusho, Saikaya, Kengou TV, Hangzhou Yongyuan'ai Biotechnology, Shanghai Yongyuan'ai Biotechnology, Aifuxi (Chongqing) Biotechnology, Alpha Trend, Saikaya Yuunokai, Nasubi, Fujitaka & Partners, FSC, AFC Smile Real Estate, AFC Smile Plus, AFC Kentaku, New World Entertainment, Rabbit Express, Rabbit Travel, AFC Tourism, 5SPRO Joint Stock Company
Press page —

Metrics

Valuation  
Market cap ¥ 12.347B
Market cap (USD) $ 77.167M
P/E 10.23
PEG 3.65
P/BV 0.75
P/S 0.36
P/OCF 7.36
P/FCF -7.05
Dividend yield 4.7%
Turnover / mcap —
Returns  
ROE 7.6%
ROI 7.3%
ROIC 11.2%
Profit margin 3.5%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 2.8%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 27.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Revenue 34.324B 32.655B 30.185B 25.579B 22.997B 22.368B 15.819B 16.253B 15.796B 15.142B 14.631B 14.415B 13.728B 14.366B 14.795B
Net profit 1.198B 1.449B 1.252B 1.103B 735.353M 1.496B 676.683M 783.292M 736.68M 465.893M 489.6M 605.503M 282.979M 572.392M 569.044M
Free cash flow — -1.752B -1.867B -1.074B 534.446M 2.091B 917.745M 585.143M 672.299M -326.327M 691.169M 599.19M — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Share price 873 864.67 832.59 792.95 768.67 1.148K 674.45 651.33 716.64 823.49 809.43 791.04 701.91 698.31 667.8
Price performance 12m 0.01 0.04 0.05 0.03 -0.33 0.7 0.04 -0.09 -0.13 0.02 0.02 0.13 0.01 0.05 —

Filed figures

Figure Aug 2017 Aug 2018 Aug 2019 Aug 2020 Aug 2021 Aug 2022 Aug 2023 Aug 2024 Aug 2025 Aug 2026
Balance sheet detail
Trade receivables (JPY) 2.05B 2.06B 2.16B 2.19B 2.24B 2.58B 2.84B 2.81B 2.93B 3.29B
↳ YoY growth +8.4% +0.2% +5.1% +1.2% +2.5% +14.9% +10.2% -1.1% +4.2% +12.1%
↳ 5y CAGR +0.9% +3.4% +4.7% +6.7% +5.4% +6.0% +7.9%
Borrowings, current (JPY) 4.59B 2.93B 3.59B 2.87B 4.99B 7B 8.22B 9.6B 18.4B 18.8B
Borrowings, non-current (JPY) 505M 1.32B 486M 1.08B 9.69B 10.1B 11.3B 13.3B 5.48B 4.61B
Bonds payable (JPY) 171M 60M — — — — — — — —
Cash and deposits (JPY) 3.39B 4.08B 4.44B 4.73B 9.22B 10.4B 11.2B 12.2B 11.3B 9.76B
Intangible assets (JPY) 103M 95.3M 149M 163M 1.65B 1.46B 1.38B 2.52B 2.02B 1.54B
Net debt (borrowings + leases - cash) (JPY) 1.71B 171M -358M -777M 5.46B 6.76B 8.36B 10.7B 12.6B 13.6B
Cash flow detail
Operating cash flow (JPY) 526M 1.22B 1.13B 1.3B 2.58B 1.49B 865M 1.54B 1.79B 1.68B
Purchases of property, plant and equipment (JPY) -852M -549M -547M -381M -492M -958M -1.94B -3.41B -3.54B -2.4B
Change in receivables (cash effect) (JPY) -159M -3.92M -106M -26.3M 294M -333M -206M 157M -147M -340M
Change in inventories (cash effect) (JPY) -172M -253M -12.7M -172M -361M 123M -633M -1.43B -890M -629M
Change in payables (cash effect) (JPY) 62.3M 121M -191M 195M -84.9M 447M -211M 278M 52M -376M
Dividends paid (cash effect) (JPY) -181M -181M -280M -350M -313M -422M -385M -419M -434M -514M
Share buybacks (cash effect) (JPY) -54,000 — — -29,000 -153M -289M -79.6M — -13.2M —
Interest paid (cash effect) (JPY) -65M -56.7M -34.1M -28.7M -31.1M -58.4M -58.8M -97.8M -193M -289M
Income taxes paid (cash effect) (JPY) -256M -181M -263M -381M -322M -994M -283M -576M -798M -831M
Operating cash flow before change in receivables (JPY) 684M 1.23B 1.24B 1.33B 2.29B 1.83B 1.07B 1.38B 1.93B 2.02B
Free cash flow (OCF - PPE - intangibles) (JPY) -326M 672M 585M 918M 2.09B 534M -1.07B -1.87B -1.75B -726M
Income detail
Research and development expense (JPY) 116M 139M 157M 166M 164M 153M 145M 148M 143M —
↳ 5y CAGR +8.9% +8.2% +5.7% +0.8% -1.1% -3.0%
Total comprehensive income (JPY) 473M 718M 738M 706M 1.52B 827M 1.14B 1.14B 1.58B 1.29B
Comprehensive income to owners (JPY) 473M 718M 738M 706M 1.52B 825M 1.14B 1.15B 1.54B 1.28B
Provision for credit losses (JPY) 4.55M 4.9M 19.9M 40.9M — — — 4.6M -1.19M —
Credit cost ratio (credit losses / average receivables) (%) 0.2% 0.2% 0.9% 1.9% — — — 0.2% 0.0% —
Segments
Department Store Business · Segment revenue (JPY) — — — — 3.21B 4.7B 5.2B 4.95B 4.62B 4.58B
↳ YoY growth +46.6% +10.7% -4.9% -6.6% -0.9%
Department Store Business · Segment operating income (JPY) — — — — -118M -249M 94.6M 33.4M 61.8M 64.9M
Food Service Business · Segment revenue (JPY) — — — — 158M 921M 1.48B 2.18B 2.41B 2.6B
↳ YoY growth +484.3% +61.1% +46.9% +10.6% +8.0%
Food Service Business · Segment operating income (JPY) — — — — -87.2M -355M -119M -71M -74.9M -16.5M
Real Estate And Consignment Business · Segment revenue (JPY) — — — — — — 1.3B 1.95B 2.71B 2.86B
↳ YoY growth +50.5% +38.9% +5.6%
Real Estate And Consignment Business · Segment operating income (JPY) — — — — — — 64.8M -268M 16.6M 29.4M
Reported Nov 28, 2017 Nov 27, 2018 Nov 26, 2019 Nov 25, 2020 Nov 25, 2021 Nov 30, 2022 Nov 27, 2024 Nov 26, 2025 Nov 26, 2025 Oct 15, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

中期経営計画策定のお知らせ Bull 2 Bear 0 Guidance

Prompts

AFC-HD AMS Life Science Co., Ltd. (ticker 2927), listed in Japan.

ETFs Holding AFC-HD AMS Life Science Co., Ltd.

ETF Weight in ETF Shares Market value As of
DFIS 0.00% 8,200 $ 43.436K Nov 12, 2026
DFIC 0.00% 10,200 $ 54.03K Nov 12, 2026
DFAX 0.00% 6,929 $ 36.703K Nov 12, 2026
AVDE 0.00% 800 $ 4,230.54 Nov 16, 2026
AVDV 0.00% 15,500 $ 81.967K Nov 16, 2026